ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
ASN Duurzaam Obligatiefonds

ASN Duurzaam Obligatiefonds (ASNOB)

25.14
-0.01
(-0.04%)
Cerrado 28 Diciembre 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
25.14
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
2,265
25.14 Rango del Día 25.14
24.12 Rango de 52 semanas 25.34
Precio Anterior
25.15
Precio de Apertura
25.14
Última hora de negociación
Volumen promedio (3 m)
7,644
Volumen financiero
-
Precio Promedio Ponderado
-

ASNOB Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.01-0.039761431411525.1525.1825.14921325.15348108DE
4-0.07-0.27766759222525.2125.3425.14408725.21963561DE
120.040.15936254980125.125.3424.86764425.02850755DE
260.843.4567901234624.325.3424.22480624.94010965DE
520.41.616814874724.7425.3424.12513524.69770766DE
156-2.4-8.7145969498927.5427.5423.34466824.76444197DE
260-3.87-13.340227507829.0129.3823.34793427.15315794DE

ASNOB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de ASN Duurzaam Obligatiefo...?
El precio actual de las acciones de ASN Duurzaam Obligatiefo... es 25.14 €
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de ASN Duurzaam Obligatiefo...?
ASN Duurzaam Obligatiefo... ha negociado en un rango de 24.12 € a 25.34 € durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
15.95 €
(2,146.48%)
2.17k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.87 €
(40.22%)
2.43M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
110.23k
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
ALEUPEuroplasma
0.0413 €
(-14.67%)
3.93M
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ATOAtos SE
0.0027 €
(17.39%)
3.02B
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
NEOENNeoen SA
39.83 €
(0.73%)
81.42M
BCPBanco Comercial Portugues SA
0.4602 €
(2.04%)
75.06M
ALHPIHopium SA
0.005 €
(0.00%)
19.56M
JustJack JustJack 2 minutos hace
Not much, if anything, to laugh about with this share selling scheme. 

Unless you are Steve or Alexoops I guess.  
AITX
YY1000 YY1000 4 minutos hace
There are two reasons cited for why the '953 patent cannot claim priority date from the '048 provisional: (1) the change from C2 to C1 (which ENTA argued was correcting a typographical error) and (2) "the disclosure of a broad genus in the ‘048 Provisional fails to provide written description suppor
ENTA PFE
sharkey1 sharkey1 4 minutos hace
BS rack 186, but I am glad to see you spending a lot of useless vile energy trashing people on this board,
takes a lot of time to come up the stuff you post.
ELTP
ddls ddls 4 minutos hace
Buy: 0 - Neutral: 129,911 - Sell: 13,816,260 😭

Friday 12/27/24
BIEL
yman yman 5 minutos hace
Hey Mungo did you try contacting the Ant man? If he thinks he has a real chance with his case, he may be interested in more shares. How many shares are you talking about, I might be interested.
NNLX
Implanting Implanting 6 minutos hace
O.K. what's being discussed in the interview IMO will be the MAJOR catalyst for a much higher gold price in the next few years. It's geopolitical in nature and it's most likely going to involve the U.S. and China in a military conflict of some sort.

The fellow in the interview is ver
FFMGF
Filterthenoise Filterthenoise 6 minutos hace
Im a shareholder
RNVA
RKMKE RKMKE 6 minutos hace
Pumpers are getting out control with their rotten theories... so tell us whats has been accomplished and what cam to fruition???


WDLF
dstock07734 dstock07734 9 minutos hace
Mike,

Enlighten me why the unpublished paper seems like having conclusion different from the one published on Nature five years ago.

The published paper states that neoadjuvant therapy can double OS in comparison of adjuvant treatment while the unpublished paper claims
NWBO
nyt nyt 9 minutos hace
All the news the emu promised to start presenting........ ITS TOO MUCH! STOP! I CAN'T TAKE IT ALL.....HALP! AAAaaaargh
VPLM
sokol sokol 10 minutos hace
The J.P. Morgan Healthcare Conference is widely regarded as the premier event in the healthcare industry. It is the largest and most influential healthcare investment symposium, attracting top executives, investors, and innovators from over 400 organizations globally. Known for shaping industry tren
AVXL
al44 al44 10 minutos hace
An easier way to show illegals the door

By Philip Lillingston

A recent article in the Wall Street Journal by a Jess Bravin reported that attorneys general of many blue states are not going to give up quietly when Donald Trump, as president, begins to honor his election
Vexari Vexari 11 minutos hace
Gaining strength

Against the cartels grip

Tide is turning

Retribution

Is near
PFE
glenn1919 glenn1919 12 minutos hace
cocp............................https://stockcharts.com/h-sc/ui?s=cocp&p=D&yr=0&mn=2&dy=12&id=p84071410134
meixatech meixatech 12 minutos hace
Pharmacological modulation of hypoxia-induced respiratory neuroplasticity

Sara Turner , Kristi Streeter , John Greer, Gordon S Mitchell, David D Fuller

PMCID: PMC6155458 NIHMSID: NIHMS987117 PMID: 29197629
Respir Physiol Neurobiol. 2017 Nov 29;256:4–14. doi: 10
RSPI
CaptainObvious CaptainObvious 12 minutos hace
I'll keep mine at .57 since we are talking the first full day after approval, and no other announcements.
NWBO
BullNBear52 BullNBear52 13 minutos hace
Mets have big Alonso decision on their hands
December 27th, 2024
Anthony DiComo

https://www.mlb.com/news/mets-biggest-question-before-2025-spring-training

By now Alonso has to be feeling unloved after the Mets signed Soto and they still haven't made a dece
glenn1919 glenn1919 14 minutos hace
cocp...........................................https://stockcharts.com/h-sc/ui?s=cocp&p=W&b=5&g=0&id=p86431144783
COCP
Genz2 Genz2 15 minutos hace
https://www.cnbc.com/amp/2024/12/28/why-microsoft-amazon-google-and-meta-are-betting-on-nuclear-power.html

Now why aren’t these companies betting on the unlimited supply of solar and mega packs with Elon!! Are we going to have another nuclear meltdown and destroy the environment?? E
gawti88 gawti88 15 minutos hace
lol bro, insane how big this company has grown. lol.... 60k+ days now haha man i remember they were doing 60k sales in a month LOL.

60k months are now 60k days. This is probably a top 5 otc pick. Get ready.
CEOS
al44 al44 16 minutos hace
Your neighbor is deep in debt

By Kevin Finn

What would you say about a family of four who earns $44,000 per year and spends $61,000? Crazy, right? It gets worse. The family is $362,000 in debt, and that debt alone is generating $10,000 a year in interest.
Clark6290 Clark6290 17 minutos hace
His name is Judge Lamberth. I fail to understand why all the derogatory names for him, think the emoji 🤔 fella started it
FNMA
flipper44 flipper44 17 minutos hace
Again, FeMike’s survey question is asked under the synthetic given that nothing else will be announced when (likely) approval is announced.

I agree with FeMike’s point that approval should not be announced in isolation.
NWBO has one temporary advantage right now. It held bac
NWBO
Dorick Dorick 17 minutos hace
Sorry to hear that, Mr. PC. Get well soon!
FLCX

Su Consulta Reciente